Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH3A1 | P30838 | 6/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | ALDH2 | P05091 | 3/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16366700 | 0.86 | CHRM5 (0.53) | ALDH3A1ALDH1A1ALDH2CHRM5CA12 | |
| SCHEMBL4625293 | 0.78 | ALDH3A1 (0.65) | ALDH3A1ALDH1A1ALDH2CHRM5CA12 | |
| SCHEMBL4624033 | 0.74 | ALDH3A1 (0.65) | ALDH3A1ALDH1A1ALDH2CA12CA1 | |
| SCHEMBL28533366 | 0.73 | ALDH3A1 (0.67) | ALDH3A1ALDH1A1ALDH2CHRM5CES1 | |
| SCHEMBL29869527 | 0.73 | ALDH3A1 (0.82) | ALDH3A1ALDH1A1ALDH2CHRM5CA12 | |
| SCHEMBL11186018 | 0.73 | ALDH3A1 (0.82) | ALDH3A1ALDH1A1ALDH2CHRM5CA12 | |
| SCHEMBL17830744 | 0.73 | ALDH1A1 (0.55) | ALDH3A1ALDH1A1ALDH2CA12CA1 | |
| SCHEMBL16048101 | 0.72 | ALDH3A1 (0.65) | ALDH3A1ALDH1A1ALDH2CHRM5CA12 | |
| SCHEMBL29220078 | 0.72 | ALDH3A1 (0.65) | ALDH3A1ALDH1A1ALDH2CHRM5CA12 | |
| SCHEMBL17286209 | 0.72 | ALDH3A1 (0.65) | ALDH3A1ALDH1A1ALDH2CHRM5CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9943506-B2 | BCL6 inhibitors as anticancer agents | CORNELL UNIVERSITY (US) | 2018-04-17 | — | — | US | disclosed |
| US-20160166549-A1 | BCL6 INHIBITORS AS ANTICANCER AGENTS | CORNELL UNIVERSITY | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166549-A1 | BCL6 INHIBITORS AS ANTICANCER AGENTS | BCL6, BCL6B, BAZ2A | ALDH3A1 4762/4885ALDH1A1 4832/4885ALDH2 4714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.